Cargando…

Multivalent adenoviral vectors which use an antigen capsid-incorporation strategy for HIV vaccination

Detalles Bibliográficos
Autores principales:	Gu, L, Li, ZC, Krendelchtchikova, V, Krendelchtchikov, A, Matthews, QL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441595/ http://dx.doi.org/10.1186/1742-4690-9-S2-P22

Ejemplares similares

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Development of an Ad5H3 Chimera Using the “Antigen Capsid-Incorporation” Strategy for an Alternative Vaccination Approach
por: Gu, Linlin, et al.
Publicado: (2016)

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy
por: Gu, Linlin, et al.
Publicado: (2014)

Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
por: Kreppel, Florian, et al.
Publicado: (2021)

Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)

Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection
por: Farrow, Anitra L., et al.
Publicado: (2014)

Increased mucosal CD4+ T-cell activation following vaccination with an adenoviral vector in rhesus macaques
por: Bukh, I, et al.
Publicado: (2012)

Epitope Capsid-Incorporation: A New Effective Approach for Vaccine Development for Chagas Disease
por: Matthews, Qiana L., et al.
Publicado: (2016)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

Progress in Adenoviral Capsid-Display Vaccines
por: Vujadinovic, Marija, et al.
Publicado: (2018)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
por: Saari, Heikki, et al.
Publicado: (2020)

Extreme genetic fragility of the HIV-1 capsid
por: Rihn, Suzannah, et al.
Publicado: (2013)

Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
por: Morse, Michael, et al.
Publicado: (2013)

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
por: Du, Samuel, et al.
Publicado: (2015)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
por: Afkhami, Sam, et al.
Publicado: (2023)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
por: Berkower, I, et al.
Publicado: (2012)

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes
por: Ruan, Merry ZC, et al.
Publicado: (2016)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Coughlan, Lynda
Publicado: (2020)

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
por: Matthews, Qiana L, et al.
Publicado: (2008)

Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging
por: Obermeyer, Allie C., et al.
Publicado: (2014)

Phage capsid nanoparticles as multivalent inhibitors of viral infections
por: Abbas, Manzar, et al.
Publicado: (2020)

P19-10. Induction of dendritic cell maturation by a liposomally-delivered multivalent HIV vaccine
por: Azizi, A, et al.
Publicado: (2009)

A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting
por: Lu, Zhi Hong, et al.
Publicado: (2020)

P19-15. Synthesis of multivalent mimotopes as potential vaccine candidates
por: Go, JG, et al.
Publicado: (2009)

HIV-1 capsid interacts with cytoskeletal-associated proteins for intracytoplasmic routing to the nucleus
por: Fernandez, Juliette, et al.
Publicado: (2013)

Thermodynamic characterization of the peptide assembly inhibitor binding to HIV-1 capsid protein
por: Kozisek, Milan, et al.
Publicado: (2013)

Strategies which ensure our patient’s safety
por: Guillaumet, G, et al.
Publicado: (2015)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Transcriptional Activation of the Adenoviral Genome Is Mediated by Capsid Protein VI
por: Schreiner, Sabrina, et al.
Publicado: (2012)

Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral Antigenicity
por: Natsume, Atsushi, et al.
Publicado: (2000)

Electrostatic repulsion regulates hiv-1 capsid hexamer plasticity and assembling capacities into core-like structures
por: Brun, Sonia, et al.
Publicado: (2009)

Adenoviral vector-based strategies against infectious disease and cancer
por: Zhang, Chao, et al.
Publicado: (2016)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
por: Tamura, Rodrigo Esaki, et al.
Publicado: (2018)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors
por: Mühle, M, et al.
Publicado: (2012)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4mnbq9nb1d6dscqja6t8sddbfl